Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 7, 2026; 32(33): 118587
Published online Sep 7, 2026. doi: 10.3748/wjg.118587
Published online Sep 7, 2026. doi: 10.3748/wjg.118587
Figure 2 Hepatitis B virus transrenal DNA fragment size distributions compared to human cell-free DNA in urine and liver-derived hepatitis B virus cell-free DNA in plasma.
A: Comparisons of DNA fragment sizes of transrenal DNA (hepatitis B virus DNA; orange) and urine cell-free DNA (human DNA; blue) from two hepatitis B patients, Pt 1 and Pt 2, with serum viral load undetectable at the time of specimen collection; B: Comparisons of hepatitis B virus DNA fragment sizes between matched urine (transrenal DNA) and plasma (cell-free DNA) from two hepatitis B patients, hepatitis I and hepatitis II, and two hepatocellular carcinoma (HCC) patients, HCC I and HCC II. Hepatitis II had a 6.9 Log IU/mL serum viral load at the time of specimen collection. The other three patients had undetectable viral load at the time of specimen collection. HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma.
- Citation: Kim AK, Lin SY, Liu HN, Jain S, Gade TP, Shieh FS, Hamilton J, Hann HW, Chang TT, Goryunov D, Wang Z, Su YH. Urinary cell-free DNA as a noninvasive liquid biopsy for hepatocellular carcinoma. World J Gastroenterol 2026; 32(33): 118587
- URL: https://www.wjgnet.com/1007-9327/full/v32/i33/118587.htm
- DOI: https://dx.doi.org/10.3748/wjg.118587